NAMPT and glioblastoma: Nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in the NAD<sup>+</sup> salvage pathway, is highly expressed in glioblastoma and represents a promising metabolic target.<h4>Methods</h4>We investigated the effects of the NAMPT inhibitor GMX1778 on ferroptosis and tumour immunogenicity in glioblastoma cells.